Lymph Node Swelling: Labs, Diagnosis, and Next Steps
A clinical guide to swollen lymph nodes covering causes, recommended lab work, imaging, biopsy criteria, and when to seek urgent evaluation.
Mental Food Obsession: When to See a Doctor
Persistent, intrusive thoughts about food can signal an eating disorder or anxiety condition. Learn when mental food obsession requires medical evaluation, what causes it, and evidence-based treatments.
Missed Periods: Drugs That Cause or Treat It
A clinical guide to medications that can cause missed periods (amenorrhea) and the drugs used to treat it, with dosing details, trial data, and when to see a doctor.
Morning Stiffness: When to See a Doctor
Morning stiffness lasting more than 30 minutes may signal inflammatory arthritis, polymyalgia rheumatica, or other treatable conditions. Learn the red flags, causes, and when to seek medical evaluation.
When to Worry About Leg Cramps (Warning Signs)
Most leg cramps are harmless, but frequent, severe, or swelling-related cramps need a doctor. See red flags, key labs, and self-care tips.
Twitch Blood Test: Which Labs to Order and Why
Muscle twitching is usually benign. Check magnesium, calcium, TSH, CK, and a metabolic panel first, then consider EMG if it persists past 3 months.
Neck Pain: When to See a Doctor and When to Worry
Learn when neck pain requires medical attention, what causes it, how doctors diagnose it, and which treatments work. Evidence-based guidance from the HealthRX.com medical team.
Nocturia: Drugs That Cause It and Drugs That Treat It
A clinical guide to medications that trigger nighttime urination (nocturia) and the pharmacologic treatments proven to reduce it, including desmopressin, antimuscarinics, and combination therapy.
Oily Skin: When to See a Doctor
Learn why your skin is oily, what causes excess sebum production, and when oily skin signals something that needs medical attention. Reviewed by board-certified physicians.
Ozempic Butt: Drugs That Cause It and Treatments That Help
Which medications cause ozempic butt, why GLP-1 drugs lead to gluteal volume loss, and the pharmacologic and procedural treatments that can restore shape and skin quality.
Painful Urination: Drugs That Cause It and Medications That Treat It
A clinical guide to dysuria covering the prescription drugs most likely to cause painful urination, the medications used to treat it, diagnostic steps, and when to seek medical care.
Pale Stool: When to See a Doctor
Learn what causes pale or clay-colored stool, when pale stool signals a serious problem like bile duct obstruction, and exactly when to see a doctor for evaluation and treatment.
Palpitations: What Could Be Causing Them
A guide to the causes, diagnosis, and treatment of heart palpitations, including when to seek emergency care and which tests your doctor may order.
Peptide-Related Flushing: A Differential and Emergency Triage Map
Evidence-led flushing triage for bremelanotide, CJC-1295 and research peptides, separating documented effects, unknown rates, allergy, and other causes.
Peptide Flushing: When to See a Doctor
Peptide flushing is common with GHRPs, BPC-157, and PT-141. Learn the causes, how to tell benign flushing from a warning sign, and when to seek medical evaluation.
Peptide Numbness: What Could Be Causing It
Peptide therapy can cause numbness and tingling through several mechanisms. Learn the differential diagnosis, when to seek help, and how clinicians evaluate peptide-related paresthesias.
Weight Loss Plateau: Drugs That Cause It and Medications That Break Through It
A guide to medications that trigger weight loss plateaus and pharmacologic strategies (GLP-1 agonists, metformin, combination therapy) proven to restart stalled progress.
Reflux Causes: GERD, Hernia, Meds and More
Reflux often stems from GERD, hiatal hernia, or slow gastric emptying. Learn key causes, diagnosis steps, and when symptoms warrant a doctor visit.
Salt Cravings: Labs, Causes, and Next Steps
Persistent salt cravings can signal adrenal insufficiency, electrolyte imbalance, or dehydration. Learn which labs to request, what causes salt cravings, and when to see a doctor.
Sleep Apnea Symptoms: Labs, Diagnosis, and Next Steps
Recognize the warning signs of sleep apnea, understand which labs and tests confirm the diagnosis, and learn the evidence-based next steps for treatment.
SSRI Discontinuation Symptoms: Labs, Diagnosis, and Next Steps
A clinical guide to SSRI discontinuation syndrome covering symptoms, diagnostic workup, lab tests to rule out mimics, tapering protocols, and when to seek urgent care.
Sulfur Burps: Drugs That Cause or Treat Them
Understand medication-related belching, sulfur-smelling burps, common remedies, symptom tracking and when to contact your prescribing team.
Sweating Reduced: Labs, Diagnosis, and Next Steps
Reduced sweating (hypohidrosis) can signal nerve damage, medication side effects, or autonomic dysfunction. Learn which labs to request, how doctors diagnose it, and what treatment options exist.
Tendinitis: What Could Be Causing It and When to Seek Treatment
A clinical guide to the causes of tendinitis, including overuse, systemic disease, medications, and aging. Covers diagnosis, treatment options, and when to worry about tendon pain.
Trouble Falling Asleep: Labs, Diagnosis, and Next Steps
Learn what labs to request, how sleep-onset insomnia is diagnosed, and the evidence-based next steps when you consistently have trouble falling asleep.
Unexplained Fever: Labs and Next Steps
A clinical guide to unexplained fever workup, including which labs to order, imaging options, when to worry, and evidence-based next steps for fever of unknown origin (FUO).
Weight Gain Labs and Next Steps: The Complete Diagnostic and Treatment Guide
Learn which lab tests to request when you experience unexplained weight gain, what the results mean, and evidence-based next steps including medications, lifestyle changes, and specialist referrals.
White Spots on Nails: Labs, Causes, and Next Steps
Learn what causes white spots on your nails, which lab tests to request, when to worry, and evidence-based treatment options. prepared by the HealthRX.com Editorial Team.
Yellow Eyes: What Could Be Causing It and When to See a Doctor
Yellow eyes signal elevated bilirubin levels. Learn the medical causes of scleral icterus, from liver disease to hemolytic anemia, how doctors diagnose it, and which treatments work.
Tadalafil (Generic) Safety for Older Adults (50-64): Dosing, Risks, and Monitoring
Evidence-based safety guide for generic tadalafil (2.5-20 mg) in adults aged 50-64, covering cardiovascular risks, drug interactions, dose adjustments, and monitoring protocols.
How to Safely Stop TB-500: A Clinician-Guided Discontinuation Protocol
Evidence-based guide to tapering and discontinuing TB-500 (thymosin beta-4 active fragment), including taper schedules, monitoring parameters, and what to expect after stopping.
Egrifta (Tesamorelin) Adolescent (12-17) Dosing: What Clinicians and Parents Should Know
Tesamorelin (Egrifta) is not FDA-approved for adolescents aged 12-17. This article covers the adult dosing benchmark, why pediatric data are absent, growth-velocity risks, and clinical alternatives for HIV-associated lipodystrophy in teens.
Egrifta (Tesamorelin) Complete Drug-Drug Interaction Profile
A clinician-grade review of tesamorelin (Egrifta) drug-drug interactions, covering antiretrovirals, cortisol-modulating agents, insulin, and growth hormone axis drugs with cited evidence.
Egrifta (Tesamorelin) Off-Label Uses: Evidence Levels for Every Indication
A guide to tesamorelin off-label uses beyond HIV lipodystrophy, including evidence levels for cognitive decline, NAFLD, body composition, and more.
Tesamorelin Overdose: A Product-and-Exposure Triage Record
What to do after accidental tesamorelin excess: emergency triage, product identity, known label risks, and the lack of a validated toxic-dose threshold.
Tesamorelin (Egrifta) Pharmacogenomics: How Genetic Variability Affects Response
Evidence-based review of tesamorelin pharmacogenomics, including GHRH receptor polymorphisms, GH1 variants, CYP metabolism considerations, and how genetic variability influences Egrifta efficacy in HIV-associated lipodystrophy.
Egrifta (Tesamorelin) Safety in Young Adults (18 to 29): What Clinicians and Patients Should Know
A clinical guide to tesamorelin (Egrifta) safety in young adults aged 18 to 29, covering side effects, monitoring, fertility considerations, and long-term use data for HIV-associated lipodystrophy.
Testosterone Cypionate Dosing for Adults Aged 30 to 49: Evidence-Based Guide
Complete guide to testosterone cypionate dosing for adults aged 30 to 49, including starting doses, titration schedules, injection frequency, monitoring labs, and dose adjustments based on clinical guidelines and trial data.
Testosterone Cypionate Cost vs. Alternatives: A Full Comparison of TRT Options
Compare testosterone cypionate pricing, efficacy, and side-effect profiles against enanthate, undecanoate (Aveed), topical gels (AndroGel), patches, and oral jatenzo. Includes real-world cost data, trial evidence, and switching guidance.
Testosterone Cypionate Future Formulations & Pipeline
A clinical overview of next-generation testosterone cypionate delivery systems, novel formulations in development, and pipeline compounds that may reshape TRT protocols.
Testosterone Cypionate Off-Label Uses With Evidence Levels
A guide to testosterone cypionate off-label applications, from female sexual dysfunction to sarcopenia, with trial-level evidence ratings for each use.
Testosterone Cypionate Self-Injection Technique: A Step-by-Step Clinical Guide
Learn the correct self-injection technique for testosterone cypionate, including intramuscular and subcutaneous methods, needle selection, site rotation, and how to minimize pain and complications.
Testosterone Enanthate Pediatric Safety: What Clinicians and Parents Need to Know About Use in Children Under 12
Evidence-based review of testosterone enanthate safety in pediatric patients under 12, including FDA labeling, bone age monitoring, weight-based dosing risks, and growth plate concerns.
Testosterone Enanthate Safety in Young Adults (18-29): What the Evidence Shows
Evidence-based safety profile of testosterone enanthate in young adults aged 18-29, covering fertility risks, cardiovascular monitoring, hematocrit thresholds, and clinical guidelines for safe prescribing.
Thymosin Alpha-1 Regulatory Status: US, EU, Canada, and UK
A country-by-country breakdown of thymosin alpha-1 (thymalfasin) regulatory status, covering FDA positioning, EMA review history, Health Canada classification, and MHRA standing.
Thymosin Alpha-1 Safety Signals and FDA Actions: What Patients and Clinicians Need to Know
A clinical review of thymosin alpha-1 (thymalfasin) safety signals, FDA regulatory actions, adverse event reports, and what the evidence says about long-term risk.
Thymosin Alpha-1 Young Adult (18 to 29) Dosing: What the Evidence Supports
Evidence-based dosing guide for thymosin alpha-1 (thymalfasin) in young adults aged 18 to 29, covering standard protocols, administration technique, monitoring, and clinical considerations.
Thymosin Alpha-1 Young Adult (18 to 29) Monitoring: Lab Schedule, Safety Checks, and What to Track
Complete monitoring guide for thymosin alpha-1 (thymalfasin) in young adults aged 18 to 29. Covers baseline labs, follow-up intervals, immune markers, fertility considerations, and when to adjust or stop therapy.
How to Know Which Diet Is Best for My Body Type
Body-type dieting lacks clinical evidence. Learn what actually predicts dietary success, including thyroid function, insulin sensitivity, and metabolic markers, plus how to match your eating pattern to your biology.
How to Read Your Hormone Lab Results: A Patient's Guide
Learn how to interpret TSH, free T4, free T3, testosterone, estradiol, and other hormone lab values. Understand reference ranges, optimal zones, and when results signal a need for treatment.
What Are the Key Safety Warnings for Zepbound (Tirzepatide)?
A guide to every major safety warning for Zepbound (tirzepatide), including the boxed warning for thyroid C-cell tumors, pancreatitis risk, gallbladder events, and renal injury.
What Is Zepbound (Tirzepatide)? Eli Lilly's Weight Loss Injection Explained
Zepbound (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for chronic weight management. Learn about dosing, clinical trial results, side effects, cost, and how it compares to semaglutide.
Which Labs Are Needed Before My Doctor Visit?
A complete guide to the blood tests and lab panels your doctor may order before a metabolic health, weight management, or hormone therapy appointment, including thyroid, lipid, glucose, and hormone panels.
Alprostadil (Caverject/MUSE) Accelerated Titration: Dosing, Safety, and Clinical Protocols
Evidence-based guide to accelerated alprostadil titration for erectile dysfunction, covering Caverject intracavernosal injection and MUSE urethral suppository dose escalation schedules, safety monitoring, and real-world protocols.
AOD-9604 Max-Dose Rationale: Titration Ceiling, Evidence Limits, and What Comes After
Clinical review of AOD-9604 (HGH fragment 176-191) maximum dosing, dose-escalation protocols, and the evidence basis for upper titration limits in fat-loss peptide therapy.
AOD-9604 Slow Titration for Sensitivity: How to Escalate Doses Safely
A guide to slow titration of AOD-9604 (HGH fragment 176-191) for patients with peptide sensitivity, covering starting doses, escalation schedules, and monitoring benchmarks.
BPC-157 Titration: What Dose-Escalation Claims Leave Unanswered
A close look at BPC-157 fast-titration claims, dose-response research, and why animal experiments do not establish a human escalation schedule.
BPC-157 Slow Titration for Sensitivity: How to Escalate Doses Safely
A guide to slow BPC-157 pentadecapeptide titration for patients with sensitivity. Covers dose escalation schedules, monitoring, and when to hold or advance.
CJC-1295 Max-Dose Rationale: How High Can You Safely Titrate?
Evidence-based guide to CJC-1295 (modified GRF 1-29) dose escalation, maximum dose ceilings, and the clinical rationale behind titration protocols for growth hormone optimization.
Avodart Slow Titration for Sensitivity: How to Dose-Escalate Dutasteride Safely
Evidence-based guide to slow titration of dutasteride (Avodart) for patients with drug sensitivity. Covers dose escalation schedules, monitoring, and managing side effects during up-titration.
